US senate hearing coming up: Bernie Sanders criticizes high price of GLP-1 drugs
The chairman of the US Senate Health Committee, Bernie Sanders, is now addressing the high prices of GLP-1 drugs in the US, reports US political media The Hill.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.